Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure

NCT03863002 is registered in ClinicalTrials.gov with Tianjin Weikai Bioeng., Ltd. as lead sponsor.

NCT NCT03863002
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03863002 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mesenchymal Stem Cell Transplantation for Acute-on-Chronic Liver Failure
Lead sponsor
Tianjin Weikai Bioeng., Ltd.
Phase
Phase 1/2
Overall status
Unknown status
Start date
October 1, 2019
Completion date
October 1, 2022
Enrollment
45 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

liver failure, acute on chronic